IDENTIFICATION OF POTENTIAL SALMONELLA TYPHI BETA-LACTAMASE TEM 1 INHIBITORS USING PEPTIDOMIMETICS, VIRTUAL SCREENING, AND MOLECULAR DYNAMICS SIMULATIONS
Keywords:S typhi, Beta-lactamase TEM 1, Antibiotic Resistance, Virtual screening, Docking, Peptidomimetics, Molecular dynamics simulation
Objective: The purpose of this study was to identify a potential peptidomimetic S. typhi Beta-lactamase TEM 1 inhibitor to tackle the antibiotic resistance among S. typhi.
Methods: The potential peptidomimetic inhibitor was identified by in silico docking of the small peptide WFRKQLKW with S. typhi Beta-lactamase TEM 1. The 3D coordinate geometry of the residues of small peptide interacting with the active site of the receptor was generated and mimics were identified using PEP: MMs: MIMIC server. All the identified mimics were docked at the active site of the receptor using Autodock 4.2 and the best-docked complex was selected on the basis of binding energy and number of H-bonds. The complex was then subjected to molecular dynamics simulations of 30 ns using AMBER 12 software package. The stereochemical stability of the Beta-lactamase TEM 1-WFRKQLKW complex was estimated with the help of Ramachandran plot using PROCHECK tool.
Results: In the present study, a new potential peptidomimetic inhibitor (ZINC05839264) of Beta-lactamase TEM 1 has been identified based on antimicrobial peptide WFRKQLKW by virtual screening of the MMsINC database. The docking and molecular simulation studies revealed that the mimic binds more tightly to the active site of the receptor than the peptide. The Ramachandran plot also shows that the Beta-lactamase TEM 1-mimic complex is stereo chemically more stable than Beta-lactamase TEM 1-WFRKQLKW complex as more number of residues (93.6%) are falling under the core region of the plot in case of the former.
Conclusion: The study shows that the peptidomimetic compound can act as a potential inhibitor of S. typhi Beta-lactamase TEM 1 and further it can be developed into more effective therapeutic to tackle the problem of antibiotic resistance.
Andino A, Hanning I. Salmonella enterica: survival, colonization, and virulence differences among serovars. Sci World J 2015:1-16. http://dx.doi.org/10.1155/2015/520179.
Gray, Jeffrey T, Paula J, Fedorka-Cray. Salmonella. Foodborne Diseases. Eds. Dean O. Cliver and Hans P. Riemann. San Francisco: Academic Press; 2002. p. 55-68.
John Threlfall E. Antimicrobial drug resistance in salmonella: problems and perspectives in food-and water-borne diseases. FEMS Microbiol Rev 2002;26:141-8.
Laxminarayan R, Chaudhury RR. Antibiotic resistance in India: drivers and opportunities for action. PLoS Med 2016;13:e1001974.
Thomas P, Boeckel V, Brower C, Gilbert M, Grenfell BT, Levin SA, et al. Global trends in antimicrobial use in food animals. PNAS 2015;112:5649-54.
Livermore DM. Î²-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557â€“84.
Izadpanah A, Gallo RL. Antimicrobial peptides. J Am Acad Dermatol 2005;52:381-90.
Bradshaw J. Cationic antimicrobial peptides: issues for potential clinical use. Biol Drugs 2003;17:233-40.
Vagner J, Qu H, H ruby VJ. Peptidomimetics, a synthetic tool of drug discovery. Curr Opin Chem Biol 2008;12:292-6.
Pandit RK, Mukherjee TK, Kumar A, Kumar V, Kaur PS. Structure prediction and assessment of beta-lactamase TEM-1 from S. typhi using molecular dynamics and simulation studies. Int J Rec Sci Res 2016;7:9509-13.
Mishra B, Leishangthem GD, Gill K, Singh AK, Das S, Singh K, et al. A novel antimicrobial peptide derived from modified N-terminal domain of bovine lactoferrin: Design, synthesis, activity against multidrug-resistant bacteria and Candida. Biochim Biophysica Acta 2013;1828:677â€“86.
Singh S, Singh H, Tuknait A, Chaudhary K, Singh B, Kumaran S, et al. PEPstr MOD: structure prediction of peptides containing natural, non-natural and modified residues. Biol Direct 2015;10:73.
Kaur H, Garg A, Raghava GPS. PEPstr: a de novo method for tertiary structure prediction of small bioactive peptides. Protein Pept Lett 2007;14:626-30.
Kozakov D, Beglov D, Bohnuud T, Mottarella S, Xia B, Hall DR, et al. How good is automated protein docking? Proteins: Struct Funct Bioinf 2013;81:2159-66.
Kozakov D, Brenke R, Comeau SR, Vajda S. PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 2006;65:392-406.
Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: an automated docking and discrimination method for the prediction of protein complexes. Bioinformatics 2004;20:45-50.
Comeau SR, Gatchell DW, Vajda S, Camacho CJ. ClusPro: a fully automated algorithm for protein-protein docking. Nucleic Acids Res 2004;32:W96-9.
Brenke R, Hall DR, Chuang GY, Comeau SR, Bohnuud T, Beglov D, et al. Application of asymmetric statistical potentials to antibody-protein docking. Bioinformatics 2012;28:2608-14.
The PyMOL Molecular Graphics System, Version 1.8 SchrÃ¶dinger, LLC; 2015.
Floris M, Masciocchi J, Fanton M, Moro S. Swimming into peptidomimetic chemical space using pepMMsMIMIC. Nucl Acids Res 2011;39 Suppl 2:W261â€“W269.
Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell D, et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comp Chem 2009;16:2785-91.
Lipinski CA. Lead-and drug-like compounds: the rule-of-five revolution. Drug Discovery Today Technol 2004;1:337â€“41.
Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J Comb Chem 1999;1:55-68.
Case DA, Darden TA, Cheatham TE III, Simmerling CA, Wang J, Duke RE, et al. AMBER 12, University of California, San Francisco; 2012.
Lindorff-Larsen K, Piana S, Palmo K, Maragakis P, Klepeis JL, Dror RO, et al. Improved side-chain torsion potentials for the Amber ff99SB protein force field. Proteins 2010;78:1950-8.
Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein. Comparison of simple potential functions for simulating liquid water. J Chem Phys 1983;79:926â€“35.
Forli S, Huey R, Pique ME, Sanner MF, Goodsell DS, Olson AJ. Computational protein-ligand docking and virtual drug screening with the Auto Dock suite. Nat Protocols 2016;11:905-19.
Laskowski RA, MacArthur MW, Moss D, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 1993;26:283-91.
Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006;22:195-201.